Surveying activated sludge changes during acclimation with artificial wastewater

Many processes in the chemical and pharmaceutical industries generate wastewater containing organic toxic compounds and other kinds of xenobiotics. Usually, biological treatments are used to degrade a great quantity of these substances. However, most of the time, the microorganisms are not adapted and the treatment can be blocked. Therefore, the first step to make a continuous reactor operative is the acclimation, i.e., the adaptation of the microorganisms to a specific substrate. During this particular step of the process there is a selection and a multiplication of specialized microorganisms and physiological transformations can occur in their metabolic system. Furthermore, combining image processing techniques have already been successfully used to elucidate the activated sludge morphological changes for both aggregated and filamentous bacteria contents, during such processes. The experimental set-up is composed of an aerated reactor and a clarifier. The sludge is recycled from the clarifier by a peristaltic pump. The complete mixing inside the reactor is guaranteed by the diffusion of air from its bottom. The reactor was inoculated with biomass collected from a wastewater treatment plant and fed with an artificial wastewater based on meat extract. During acclimation, chemical parameters were measured in the influent, reactor and effluent, in order to verify the stability of the process. To complete the evaluation of the process, microscopy acquisition and image processing and analysis techniques were performed for aggregates and filamentous bacteria characterization for bright field, Gram and poly-β-hydroxybutyrate (PHB) staining images. The information extracted from those images allowed for aggregates and filamentous bacteria contents inspection, identification of PHB storing microorganisms and, gram-positive and gram-negative filamentous bacteria recognition. Figure 1 presents activated sludge samples at the beginning and at the end of the acclimation phase. It was found in this study that biomass changes during the acclimation phase could be effectively monitored, combining image analysis information and chemical parameters

To buy or not to buy-evaluating commercial AI solutions in radiology (the ECLAIR guidelines).

Artificial intelligence (AI) has made impressive progress over the past few years, including many applications in medical imaging. Numerous commercial solutions based on AI techniques are now available for sale, forcing radiology practices to learn how to properly assess these tools. While several guidelines describing good practices for conducting and reporting AI-based research in medicine and radiology have been published, fewer efforts have focused on recommendations addressing the key questions to consider when critically assessing AI solutions before purchase. Commercial AI solutions are typically complicated software products, for the evaluation of which many factors are to be considered. In this work, authors from academia and industry have joined efforts to propose a practical framework that will help stakeholders evaluate commercial AI solutions in radiology (the ECLAIR guidelines) and reach an informed decision. Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services. KEY POINTS: • Numerous commercial solutions based on artificial intelligence techniques are now available for sale, and radiology practices have to learn how to properly assess these tools. • We propose a framework focusing on practical points to consider when assessing an AI solution in medical imaging, allowing all stakeholders to conduct relevant discussions with manufacturers and reach an informed decision as to whether to purchase an AI commercial solution for imaging applications. • Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services

Hall Effect of Spin Waves in Frustrated Magnets

We examine a possible spin Hall effect for localized spin systems with no charge degrees of freedom. In this scenario, a longitudinal magnetic field gradient induces a transverse spin current carried by spin wave excitations with an anomalous velocity which is associated with the Berry curvature raised by spin chirality, in analogy with anomalous Hall effects in itinerant electron systems. Our argument is based on a semiclassical equations of motion applicable to general spin systems. Also, a microscopic model of frustrated magnets which exhibits the anamalous spin Hall effect is presented.Comment: 5 pages, title and presentation style are changed, accepted for publication in Phys. Rev. Let

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to evaluate the activity and tolerability of this combination in patients refractory to standard gemcitabine (GEM). A total of 33 patients (median age of 57) were included with locally advanced and metastatic evaluable diseases, who had progressed during or following GEM therapy. The GEMOX regimen consisted of 1000 mg m−2 of GEM at a 100-min infusion on day 1, followed on day 2 by 100 mg m−2 of oxaliplatin at a 2-h infusion; a cycle that was given every 2 weeks. All patients received at least one cycle of GEMOX (median 5; range 1–29). Response by 31 evaluable patients was as follows: PR: 7/31(22.6%), s.d. ⩾8 weeks: 11/31(35.5%), s.d. <8 weeks: 1/31(3.2%), PD: 12/31(38.7%). Median duration of response and TTP were 4.5 and 4.2 months, respectively. Median survival was 6 months (range 0.5–21). Clinical benefit response was observed in 17/31 patients (54.8%). Grade III/IV non-neurologic toxicities occurred in 12/33 patients (36.3%), and grade I, II, and III neuropathy in 17(51%), 3(9%), and 4(12%) patients, respectively. GEMOX is a well-tolerated, active regimen that may provide a benefit to patients with advanced pancreatic cancer after progression following standard gemcitabine treatment

The spine of the swan: A Herschel study of the DR21 ridge and filaments in Cygnus X

In order to characterise the cloud structures responsible for the formation of high-mass stars, we present Herschel observations of the DR21 environment. Maps of the column density and dust temperature unveil the structure of the DR21 ridge and several connected filaments. The ridge has column densities larger than 1e23/cm^2 over a region of 2.3 pc^2. It shows substructured column density profiles and branching into two major filaments in the north. The masses in the studied filaments range between 130 and 1400 Msun whereas the mass in the ridge is 15000 Msun. The accretion of these filaments onto the DR21 ridge, suggested by a previous molecular line study, could provide a continuous mass inflow to the ridge. In contrast to the striations seen in e.g., the Taurus region, these filaments are gravitationally unstable and form cores and protostars. These cores formed in the filaments potentially fall into the ridge. Both inflow and collisions of cores could be important to drive the observed high-mass star formation. The evolutionary gradient of star formation running from DR21 in the south to the northern branching is traced by decreasing dust temperature. This evolution and the ridge structure can be explained by two main filamentary components of the ridge that merged first in the south.Comment: 8 pages, 5 figures, accepted for publication as a Letter in Astronomy and Astrophysic

Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.

Acute decompensation and death have been observed in patients with acute hepatitis E virus (HEV) infection and preexisting liver cirrhosis. However, the clinical, laboratory and histological features need to be fully characterised. Some of us recently described the histological presentation of hepatitis E in a large panel of liver tissue specimens. Here, we conducted a case-control study to investigate the clinical and laboratory features of the subset of patients with HEV-related acute-on-chronic liver failure (ACLF) and death. Each patient was matched to three control patients with histologically confirmed severe alcoholic hepatitis based on sex, age, total bilirubin, INR, serum creatinine and MELD score on admission. Of 5 patients who died in a context of HEV-related ACLF, 3 (60%) were male and the median age was 66 years (range 51&amp;ndash;76). Median alanine aminotransferase (ALT) at presentation was 2610 U/l (range 705&amp;ndash;3134) and aspartate aminotransferase (AST) 2818 U/l (range 1176&amp;ndash;8611). Liver function was heavily altered in all patients. Histological analyses revealed steatohepatitis on a background of cirrhosis, suggestive of an alcoholic or nonalcoholic origin. Based on histopathology, alcoholic hepatitis was initially suspected in two patients and corticosteroid treatment was initiated. Ribavirin was started in four patients. Median time from hospitalisation to death was 17 days (range 6&amp;ndash;25 days). AST levels in patients with HEV-related ACLF were significantly higher as compared to the matched patients with severe alcoholic hepatitis. Typical histopathological features of viral hepatitis may be absent in ACLF caused by HEV infection. HEV infection should be sought in acute decompensation of cirrhosis and ACLF even in the absence of histological changes suggesting viral infection

Far-infrared observations of a massive cluster forming in the Monoceros R2 filament hub

We present far-infrared observations of Monoceros R2 (a giant molecular cloud at approximately 830 pc distance, containing several sites of active star formation), as observed at 70 μm, 160 μm, 250 μm, 350 μm, and 500 μm by the Photodetector Array Camera and Spectrometer (PACS) and Spectral and Photometric Imaging Receiver (SPIRE) instruments on the Herschel Space Observatory as part of the Herschel imaging survey of OB young stellar objects (HOBYS) Key programme. The Herschel data are complemented by SCUBA-2 data in the submillimetre range, and WISE and Spitzer data in the mid-infrared. In addition, C18O data from the IRAM 30-m Telescope are presented, and used for kinematic information. Sources were extracted from the maps with getsources, and from the fluxes measured, spectral energy distributions were constructed, allowing measurements of source mass and dust temperature. Of 177 Herschel sources robustly detected in the region (a detection with high signal-to-noise and low axis ratio at multiple wavelengths), including protostars and starless cores, 29 are found in a filamentary hub at the centre of the region (a little over 1% of the observed area). These objects are on average smaller, more massive, and more luminous than those in the surrounding regions (which together suggest that they are at a later stage of evolution), a result that cannot be explained entirely by selection effects. These results suggest a picture in which the hub may have begun star formation at a point significantly earlier than the outer regions, possibly forming as a result of feedback from earlier star formation. Furthermore, the hub may be sustaining its star formation by accreting material from the surrounding filaments